Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_assertion type Assertion NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_head.
- NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_assertion description "[An 89-year-old man with severe hypertension (190/82 mm Hg) and chronic heart failure (New York Heart Association class II) despite treatment with benidipine, doxazosin mesylate (INN, doxazosin), and furosemide was given oral candesartan cilexetil (4 mg/d), an angiotensin II type 1 receptor blocker metabolized via cytochrome p450 (CYP) 2C9.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_provenance.
- NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_assertion evidence source_evidence_literature NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_provenance.
- NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_assertion SIO_000772 14586391 NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_provenance.
- NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_assertion wasDerivedFrom befree-20150227 NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_provenance.
- NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_assertion wasGeneratedBy ECO_0000203 NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_provenance.